EGFR and neoplasm: EET receptor(s) have not yet been clearly identified, but the putative GPCR/PPAR/RXR pathway, endothelial growth factor receptor (EGFR) and vascular endothelial growth factor signaling are potential targets for EETs to promote tumor growth and metastasis [28–30].